Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2026

Share-Based Payment Arrangement [Abstract]

During the nine months ended September 30, 2026, the following stock-based awards were granted to directors, executive officers and other employees. All awards were granted under the 2019 Amended and Restated Long-Term Incentive Plan.


Type of Award	Quarter Awarded	Target Shares or Units	Weighted Average Grant Date Fair Value




Restricted Stock Units (1)	1st Quarter	522,980	$	31.64
	2nd Quarter	41,708	$	41.49
	3rd Quarter	30,683	$	47.67

Performance Stock Units (2)	1st Quarter	525,474	$	31.65
	2nd Quarter	3,498	$	33.58
	3rd Quarter	11,556	$	52.68

__________

(1)Restricted Stock Units (“RSUs”) awarded to certain officers and employees during the first, second and third quarters of 2026 vest 50% after 24 months and an additional 25% on the third and fourth anniversaries of the grant date. Included in the second quarter RSUs are 31,931 units awarded to the Board of Directors for their annual fee, vesting one year from the date of the award. Upon vesting, the outstanding number of RSUs vested are converted into common stock.

(2)Performance Stock Units (“PSUs”) were awarded to certain executive officers and other employees during the first and third quarters of 2026 with a target of 392,556 shares and performance metrics tied to the Company’s revenue compounded annual growth rate (“CAGR”) from 2026 through 2028 and total shareholder return (“TSR”) relative to its peers (“Relative TSR”) with a payout ranging from 0% to 200% upon achievement of specific revenue CAGR and relative TSR goals (the “2026 CAGR TSR PSUs”). The 2026 CAGR TSR PSUs vest at the end of the three-year period upon determination of the results at the end of the performance period. PSUs were awarded to certain employees during the first and second quarters of 2026 with a target of 49,950 shares and performance metrics tied to the achievement of sales quota goals.

Schedule of Stock Based Compensation Expense

Non-cash stock-based compensation expense is included in the following line items on the Condensed Consolidated Statements of Operations as follows for the periods presented:


	Three Months Ended				Nine Months Ended
(in thousands)	September 30, 2026		September 30, 2025		September 30, 2026		September 30, 2025
Costs of goods sold	$	695	$	706	$	2,824	$	1,406
Sales and marketing	2,176		1,524		5,737		3,422
Research and development	1,826		1,047		5,040		2,796
General and administrative	4,097		2,147		10,802		5,877
Total non-cash stock-based compensation expense	$	8,794	$	5,424	$	24,403	$	13,501